Hypertensive Heart Disease

Slide 1 · Hypertensive

Heart Disease

Pressure overload • Ventricular remodeling • Clinical consequences

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning objectives

Define hypertensive heart disease and distinguish systemic from pulmonary forms.

Explain how pressure overload produces myocyte hypertrophy and interstitial fibrosis.

Recognize gross and microscopic changes in systemic and pulmonary HHD.

Connect remodeling to ischemia, arrhythmia, heart failure, and reversibility.

Apply clinicopathologic criteria and avoid common diagnostic misattribution.

Slide 3 · One disease concept, two ventricular targets

Systemic arterial hypertension

Pulmonary arterial hypertension

Sustained pressure work falls primarily on the left ventricle.

Adaptive response: Concentric LV hypertrophy.

Late effects: Stiffness, ischemia and dysfunction.

Pulmonary vascular load primarily affects the right ventricle.

Chronic response: RV hypertrophy, often with dilation.

Acute pressure crisis: RV dilation can precede hypertrophy.

Slide 4 · Pressure overload is the initiating lesion

Raised arterial pressure

Higher ventricular pressure work

Cardiomyocyte hypertrophy

Remodeling and dysfunction

Hypertension increases afterload; The ventricle must generate greater pressure to eject blood. The gross phenotype depends on which vascular circuit is hypertensive.

Slide 5 · Hypertrophy initially compensates—then can harm

Early compensation

Later maladaptation

Greater muscle mass helps meet the increased mechanical demand.

The chamber may initially retain systolic performance.

Increased stiffness impairs filling.

Increased oxygen demand and fibrosis erode functional reserve.

Dilation, congestive failure or sudden death may follow.

Slide 6 · Systemic and pulmonary disease are not interchangeable

Question

Systemic HHD

Pulmonary HHD

Major load

Systemic pressure

Pulmonary vascular pressure

Primary target

Left ventricle

Right ventricle

Characteristic pattern

Concentric LV hypertrophy

RV hypertrophy ± dilation

Alternative term

Left-sided HHD

Cor pulmonale when isolated

Slide 7 · Pressure versus volume overload

Property

Pressure overload

Volume overload

Examples

Hypertension; Aortic stenosis

Valvular regurgitation

Sarcomere addition

Predominantly parallel

Predominantly in series

Early geometry

Thickened wall

Expanded chamber

Principal remodeling

Concentric hypertrophy

Dilation with hypertrophy

Slide 8 · Cardiomyocytes enlarge rather than divide

Persistent mechanical stimulus

More protein synthesis

More sarcomeres and mitochondria

Larger myocyte and heart

Myocardial hypertrophy reflects cellular enlargement rather than replacement by newly divided cardiomyocytes. The cumulative effect is increased cardiac mass.

Slide 9 · Parallel sarcomeres enlarge the myocyte cross-section

Before pressure overload

With pressure overload

Schematic of sarcomeres: Parallel addition expands cell width rather than simply elongating the cell.

Slide 10 · Nuclear enlargement accompanies myocyte hypertrophy

Hypertrophic myocytes often show enlarged or multiple nuclei.

Increased nuclear DNA content follows replication without cell division.

A large, enlarged nucleus supports cellular hypertrophy but is not disease-specific.

Size differences may require comparison with unaffected myocardium.

Slide 11 · Why capillary supply becomes relatively inadequate

Myocardial mass increases

Capillary density does not rise proportionately

Oxygen delivery per muscle mass declines

Ischemic susceptibility increases

This supply–demand vulnerability is especially important in pressure-overload hypertrophy. Do not confuse relative capillary insufficiency with proof of epicardial coronary stenosis.

Slide 12 · Why oxygen demand rises in hypertrophied hearts

Greater myocardial O₂ demand

More muscle mass

Increased workload

Heart rate / contractility

Reduced supply reserve

Mass, rate and contractile state contribute to myocardial oxygen consumption. • Ischemia can arise from supply–demand imbalance even without a newly occluded coronary artery.

Slide 13 · Fibrosis is a second major remodeling pathway

Mechanical stress

Fibroblast matrix synthesis

Interstitial fibrosis

Reduced ventricular compliance

Mechanical forces activate myocardial fibroblasts and extracellular matrix deposition. The structural cost is resistance to diastolic filling.

Slide 14 · Cellular hypertrophy and fibrosis are distinct findings

Myocyte response

Stromal response

Increased transverse cell diameter.

Nuclear enlargement and altered gene expression.

More contractile and mitochondrial material.

Perivascular collagen deposition.

Interstitial collagen between myocytes.

Stiffer ventricular wall and impaired filling.

Slide 15 · Hypertrophic signaling includes gene reprogramming

Immediate-early growth-associated genes include FOS, JUN, MYC and EGR1.

Persistent overload may reactivate proteins associated with fetal cardiac development.

Examples include fetal myosin forms, natriuretic peptides and collagen programs.

These molecular changes accompany tissue remodeling; They are not standalone HHD diagnostic tests.

Slide 16 · A reinforcing cycle reduces functional reserve

Pressure overload

Hypertrophy

Supply–demand mismatch

Myocyte injury / fibrosis

Fibrosis decreases compliance while hypertrophy increases metabolic demand.

The originally protective response becomes increasingly maladaptive.

Slide 17 · Systemic HHD: Core pathologic criteria

Required element

What pathology must establish

1. Left ventricular hypertrophy

Usually concentric; Not otherwise explained by another cardiovascular lesion

2. Evidence of hypertension

Clinical history or pathologic evidence in another organ, such as kidney

Diagnostic interpretation

Both elements must be considered together

Slide 18 · LV hypertrophy alone does not establish systemic HHD

Supports hypertensive cause

Requires alternative consideration

Documented longstanding systemic hypertension.

Concentric left ventricular enlargement.

Concordant renal or other vascular hypertensive pathology.

Pressure overload from aortic stenosis.

Primary myocardial disease with hypertrophy.

Other cardiovascular causes of increased LV mass.

Slide 19 · The typical LV phenotype is concentric

Reference geometry

Concentric thickening

Conceptual cross-section — schematic, not a specimen

Ventricular wall becomes thicker with initially little or no chamber dilation. • Heart weight rises more than overall heart dimensions.

Slide 20 · LV wall thickness increases before dilation

Normal ventricular geometry

Concentric wall thickening

Progressive stiffening

Possible dilation in failure

The first three stages describe the common pressure-overload trajectory. Late dilation is possible, not inevitable.

Slide 21 · Gross pathology: Increased mass without equal enlargement

Pressure overload causes disproportionate thickening of the left ventricular wall.

Overall cardiac dimensions may be less impressive than the increase in heart weight.

Heart weight may exceed 500 g in advanced examples.

This example is not a threshold required for diagnosis.

Slide 22 · Marked LVH may exceed 2 cm in wall thickness

The hypertrophied left ventricular wall may exceed 2.0 cm in severe systemic HHD.

Such dimensions illustrate severity; They are not the minimal diagnostic criterion.

Correlate measurements with specimen orientation, patient context and competing causes.

Pressure-overloaded hearts may later dilate and alter apparent wall thickness.

Slide 23 · How concentric LVH alters chamber geometry

Reference geometry

Concentric thickening

Conceptual cross-section — schematic, not a specimen

Compared with a normal LV, concentric hypertrophy increases wall-to-cavity proportion. • A small cavity need not signify severe systolic impairment.

Slide 24 · Heart weight can reveal hypertrophy when the wall looks normal

A dilated, hypertrophied ventricle may show normal or reduced apparent wall thickness.

Therefore wall thickness alone underestimates hypertrophy in some failing hearts.

Heart weight is a better measure of hypertrophy in dilated hearts.

Interpret mass and chamber geometry together.

Slide 25 · Early microscopic change: Greater myocyte diameter

Very early change

Why it may be missed

Increased myocyte transverse dimension is the first microscopic abnormality.

The change can precede striking nuclear morphology.

Routine histology may not make small size increases obvious.

Section orientation and sampling can obscure comparisons.

Do not overdiagnose isolated myocyte enlargement.

Slide 26 · Advanced myocardial hypertrophy: Cellular and nuclear changes

Original schematic: Cardiomyocyte profiles and enlarged myocyte nuclei

Slide 27 · Perivascular fibrosis: Collagen around small vessels

Vessel without prominent fibrosis

Vessel with perivascular fibrosis

Original conceptual schematic—not a histologic specimen.

Slide 28 · Interstitial fibrosis: Stiffness between myocytes

Original schematic: Cardiomyocyte profiles and interstitial collagen bands

Slide 29 · The stiff LV fills at higher pressure

LV wall thickening and fibrosis

Reduced compliance

Impaired diastolic filling

Raised upstream atrial pressure

Mechanical stiffness is a direct mechanistic bridge from gross LVH to atrial consequences.

Slide 30 · Why the left atrium enlarges

High LV filling resistance

Left atrial pressure burden

Left atrial enlargement

Increased risk of atrial fibrillation

Left atrial enlargement may be an important secondary structural sign of diastolic dysfunction.

Slide 31 · Atrial fibrillation may be the first presentation

Compensated hypertensive LVH may be clinically silent.

Enlargement of the left atrium creates an arrhythmogenic substrate.

Some patients first come to attention because of newly recognized atrial fibrillation.

The rhythm abnormality does not by itself prove hypertensive etiology.

Slide 32 · Compensated disease can be detected before symptoms

Subclinical course

Available clinical clues

Myocardium maintains adequate output initially.

No symptoms are required for substantial LV hypertrophy.

Electrocardiographic evidence of LV enlargement.

Echocardiographic evidence of ventricular hypertrophy.

Longstanding hypertension and associated organ changes.

Slide 33 · From silent hypertrophy to overt failure

Sustained hypertension

Compensated LV hypertrophy

Fibrosis / impaired filling

Possible CHF / dilation

Progression depends on burden, duration and adequacy of blood-pressure control. Not every patient traverses every stage.

Slide 34 · Demand ischemia: Increased need without enough reserve

Hypertrophied myocardium

Higher oxygen requirement

Relative capillary insufficiency

Myocardial demand ischemia

Increased oxygen requirement is a direct mechanism of demand ischemia in systemic HHD.

Slide 35 · Systemic hypertension also promotes coronary disease

Epicardial coronary pathway

Intramyocardial demand pathway

Hypertension potentiates coronary atherosclerosis.

Coronary disease can therefore coexist with LV hypertrophy.

More muscle increases myocardial oxygen consumption.

Reduced supply reserve makes ischemia possible without plaque rupture.

Slide 36 · Cardiac dilation signals loss of compensation

Initially concentric LV hypertrophy is commonly non-dilated.

With worsening myocardial dysfunction, chamber dilation may supervene.

A dilated heart may have greater mass without dramatically thick walls.

Do not equate late dilation solely with a primary dilated cardiomyopathy.

Slide 37 · CHF links myocardial remodeling to systemic illness

Cardiac basis

Downstream effects

LV dysfunction or elevated filling pressure.

Left atrial and pulmonary venous pressure may rise.

Pulmonary congestion and edema.

Reduced forward perfusion of organs.

Symptoms evolve with severity of decompensation.

Slide 38 · Left-sided failure produces pulmonary congestion

Elevated left-heart filling pressure

Pulmonary vascular congestion

Interstitial / alveolar edema

Breathlessness

This section is heart-failure context, not required to diagnose compensated HHD.

Slide 39 · Diastolic and systolic problems must be distinguished

Question

Predominant diastolic problem

Advanced contractile impairment

Structural contributor

Thick, fibrotic, noncompliant LV

Decompensated remodeled ventricle

Main physiologic issue

Resistance to ventricular filling

Reduced pumping ability

Potential consequence

Elevated filling pressures

Dilation and CHF

Caution

May precede overt systolic dysfunction

Not universal in HHD

Slide 40 · Clinical outcomes are heterogeneous

Systemic HHD trajectory

Stable compensation

IHD / ischemia

Progressive CHF

Sudden cardiac death

Some patients remain compensated; Others develop ischemia, CHF, or sudden cardiac death. • Blood-pressure severity, duration, cause and control influence outcome.

Slide 41 · Sudden death is possible—but not inevitable

Marked HHD increases vulnerability to clinically serious outcomes.

Sudden cardiac death is among the possible clinical outcomes.

Fibrosis, ischemia and electrical instability are relevant pathophysiologic context.

Avoid inferring an individual patient’s mode of death from LVH alone.

Slide 42 · Blood-pressure control can reverse remodeling

Sustained hypertension

Effective pressure control

Prevention or regression of LVH

Reduced HHD-associated risk

Controlling pressure load may prevent hypertrophy or permit its regression. Regression is possible but depends on clinical circumstances.

Slide 43 · The RV normally operates in a low-pressure circuit

Physiologic RV design

Effect of pulmonary hypertension

Thinner wall and greater compliance than the LV.

Adapted to the lower resistance of the pulmonary circulation.

Higher pressure work stresses the RV.

Acute load may dilate the chamber.

Persistent load favors hypertrophy.

Slide 44 · Cor pulmonale is an RV pressure-overload phenotype

Pulmonary vascular load rises

RV pressure overload

RV remodeling

Possible right-sided failure

Isolated pulmonary hypertensive heart disease is termed cor pulmonale. Pulmonary hypertension from left heart disease is common, but should be etiologically distinguished from isolated cor pulmonale.

Slide 45 · Pulmonary hypertension can originate in different places

Pathway

Illustrative cause

RV implication

Pulmonary parenchymal disease

Emphysema / chronic lung disease

Chronic RV loading

Primary pulmonary vascular disease

Primary pulmonary hypertension

Chronic RV loading

Pulmonary vascular obstruction

Massive embolism

Acute RV pressure crisis

Left-heart pathology

Secondary pulmonary hypertension

RV involvement secondary to left disease

Slide 46 · Chronic lung disease is a typical cor pulmonale driver

Chronic pulmonary parenchymal disease

Pulmonary vascular pressure elevation

Sustained RV afterload

Hypertrophy ± dilation

Emphysema is explicitly given as an example. The source does not require all chronic lung disease to cause cor pulmonale.

Slide 47 · Primary pulmonary hypertension can remodel the RV

A pulmonary vascular disease can impose sustained pressure work without primary LV failure.

The ventricle adapts by hypertrophy but may subsequently dilate.

Progressive pressure loading may culminate in isolated right-sided failure.

Persistent pulmonary arterial pressure overload determines the RV remodeling response.

Slide 48 · Massive pulmonary embolism causes acute cor pulmonale

Abrupt vascular obstruction

Sudden rise in pulmonary resistance

Acute RV pressure overload

Marked RV dilation

A rapid obstruction does not allow time for established hypertrophy.

Slide 49 · Acute cor pulmonale: Dilated RV without hypertrophy

Crescent-shaped RV

Acute dilation

Conceptual cross-section — schematic, not a specimen

Right ventricular dilation dominates the gross picture. • In cross-section, the normally crescent-shaped RV may become ovoid.

Slide 50 · Chronic cor pulmonale: RV hypertrophy and dilation

Crescent-shaped RV

Chronic hypertrophy + dilation

Conceptual cross-section — schematic, not a specimen

Right ventricular free wall thickens under sustained load. • Dilation often coexists with hypertrophy.

Slide 51 · RV wall thickness can reach 1 cm or more

Right ventricular wall thickness may reach 1.0 cm or more in advanced chronic cases.

This describes advanced morphology, not an obligatory cutoff for cor pulmonale.

Relative chamber enlargement and associated tissue changes still matter.

Interpret measurements in anatomical and clinical context.

Slide 52 · Subtle RV hypertrophy may involve the outflow tract

RV outflow tract

Moderator band

Muscle bundles just below the pulmonary valve may thicken.

Changes may reveal early or limited RV hypertrophy.

The moderator band may become prominent.

It spans septum to the anterior RV papillary muscle.

This is a normal muscular structure that can hypertrophy.

Slide 53 · Severe RV remodeling can distort the left ventricle

RV hypertrophy / dilation

Chamber expansion

Left ventricular compression or shape change

Potential LV filling impairment

Slide 54 · Tricuspid dysfunction can complicate RV enlargement

Progressive RV enlargement

Tricuspid apparatus distortion

Tricuspid regurgitation

Additional RV volume load

Some affected hearts also show fibrous thickening of the tricuspid valve.

Slide 55 · Chronic and acute cor pulmonale differ in tempo

Feature

Acute cor pulmonale

Chronic cor pulmonale

Time course

Abrupt pressure loading

Persistent pressure loading

Common context

Massive pulmonary embolism

Lung or pulmonary vascular disease

Dominant gross change

Marked RV dilation

RV hypertrophy ± dilation

Wall hypertrophy

Not established

May be pronounced

Slide 56 · RV failure produces a different congestion pattern

Left-sided failure

Predominantly right-sided failure

Pulmonary venous congestion and edema.

Dyspnea reflects pulmonary fluid accumulation.

Systemic and portal venous engorgement.

Organ congestion predominates.

Pulmonary congestion can be relatively limited if isolated.

Slide 57 · Most right-sided failure follows left-sided disease

An elevated pulmonary pressure can transmit downstream from failing left chambers.

Therefore right-sided failure is most commonly secondary to left-sided failure.

This differs from isolated cor pulmonale caused by pulmonary disease.

Clinical attribution requires knowing where the pressure elevation originated.

Slide 58 · Systemic versus pulmonary HHD: Gross patterns

Feature

Systemic hypertension

Pulmonary hypertension

Chamber most affected

Left ventricle

Right ventricle

Classic pattern

Concentric LV wall thickening

RV enlargement ± hypertrophy

Associated chamber change

Left atrial enlargement

Possible LV shape distortion

Advanced consequence

LV dysfunction / CHF

Right-sided failure

Slide 59 · Systemic versus pulmonary HHD: Clinical reasoning

Clinical clue

Favor systemic HHD

Favor cor pulmonale

Pressure history

Systemic hypertension

Pulmonary hypertension / lung disease

Structure

LVH and possible LA enlargement

RV hypertrophy or dilation

Possible vascular pathology

Renal hypertension-related changes

Pulmonary parenchymal / vascular abnormalities

Important caution

Rule out alternative LVH causes

Rule out secondary PH from left-heart disease

Slide 60 · A morphologic diagnosis needs an etiologic correlation

Identify involved chamber

Characterize hypertrophy and dilation

Assess pressure-source history

Review competing structural lesions

Systemic HHD diagnosis requires two complementary pathologic criteria. For right-sided disease, establish why RV pressure overload occurred.

Slide 61 · Diagnostic pitfalls in hypertensive remodeling

Concentric LVH is suggestive but not specific for systemic hypertension.

Late dilatation may mask the original concentric pattern.

Perivascular/interstitial fibrosis occurs in several cardiac disorders.

An enlarged RV may reflect left-sided disease rather than isolated cor pulmonale.

The listed wall/weight measurements are examples, not universal thresholds.

Slide 62 · Case: Concentric LVH with atrial fibrillation

Clinical vignette

A patient with years of systemic hypertension has echocardiographic concentric LV thickening and a new diagnosis of atrial fibrillation. No primary valve lesion is evident.

Reasoning task

What structural link best explains the arrhythmia?

Identify the pressure-loaded chamber.

Relate compliance to left atrial pressure.

Predict the key secondary chamber change.

Slide 63 · Case interpretation: LV stiffness → LA enlargement

Hypertension-driven LVH

Fibrosis and reduced compliance

Left atrial enlargement

Predisposition to atrial fibrillation

Atrial arrhythmia is clinically compatible with HHD but is not specific for it.

Slide 64 · Case: Collapse with sudden RV dilation

Clinical vignette

A patient deteriorates abruptly after a large pulmonary embolus. Cardiac examination demonstrates a prominently dilated RV without convincing wall hypertrophy.

Reasoning task

Does the morphology favor acute or chronic pressure overload?

Judge the time available for structural remodeling.

Contrast dilation with muscular hypertrophy.

Connect the finding to pulmonary vascular obstruction.

Slide 65 · Case interpretation: Acute cor pulmonale

Massive pulmonary embolism

Abrupt pulmonary afterload increase

RV dilation without hypertrophy

Acute right-heart compromise

Conclude an acute pressure-overload phenotype. A chronic substrate cannot be excluded solely from the schematic case.

Slide 66 · Case: A remodeled RV in chronic lung disease

Clinical vignette

A patient with longstanding emphysema has RV free-wall thickening, a prominent moderator band and chamber dilation.

Reasoning task

What lesion and mechanism connect these findings?

Explain the role of sustained pulmonary vascular load.

Recognize chronic RV hypertrophy with dilation.

Consider whether left-sided disease also contributes.

Slide 67 · Case interpretation: Chronic cor pulmonale

Chronic pulmonary disease

Persistently elevated RV afterload

RV hypertrophy plus dilation

Risk of right-sided failure

Moderator band thickening may provide an additional morphologic clue.

Slide 68 · Integrated synthesis: Load → structure → consequences

Pressure circuit

Primary remodeling

Major potential consequences

Systemic

LV concentric hypertrophy; Fibrosis

LA enlargement, ischemia, CHF, SCD

Pulmonary—acute

RV dilation

Acute RV dysfunction

Pulmonary—chronic

RV hypertrophy ± dilation

RV failure, tricuspid regurgitation, LV distortion

Slide 69 · Four high-yield principles

Pressure overload is the defining initiating mechanism of HHD.

Hypertrophy compensates initially; Fibrosis and oxygen mismatch reduce reserve.

Systemic HHD classically produces concentric LVH; Chronic cor pulmonale targets the RV.

Etiologic correlation is essential: Morphology alone rarely identifies the pressure source.

Slide 70 · Final application: assign the pressure source

Concentric LVH with corroborating systemic hypertension and no alternative load → systemic HHD.

Abrupt RV dilation following massive embolism without developed wall hypertrophy → acute cor pulmonale.

RV wall and moderator-band hypertrophy in chronic pulmonary disease → chronic cor pulmonale.

Coexisting LV and RV disease requires investigation of pulmonary pressure secondary to left-sided dysfunction.